Paf1 activators constitute a specialized category of chemical compounds known for their ability to modulate the activity of the Paf1 complex, a crucial player in the regulation of transcription and chromatin dynamics in eukaryotic cells. The Paf1 complex, comprised of multiple subunits including Paf1, Ctr9, Leo1, and others, plays a pivotal role in coordinating gene expression by RNA polymerase II (RNAPII). These activators are meticulously designed to interact with components of the Paf1 complex, influencing its function in gene transcription. At the molecular level, the mechanisms underlying Paf1 activation can be intricate, involving binding to specific subunits of the complex or regions within them, potentially inducing conformational changes that enhance the association of the Paf1 complex with RNAPII and other transcription factors.
The study of Paf1 activators is instrumental in advancing our understanding of transcriptional regulation and the intricate machinery governing gene expression. Research in this field primarily focuses on elucidating the precise molecular mechanisms by which these compounds impact the function of the Paf1 complex and, consequently, gene transcription. Understanding the role of Paf1 activators contributes to our broader knowledge of molecular biology and the intricate interplay of proteins and factors involved in orchestrating gene expression in cells. Moreover, these compounds serve as invaluable tools for scientists seeking to investigate the molecular basis of transcriptional regulation, ultimately deepening our understanding of the processes that drive gene expression and their potential implications in various scientific and biomedical contexts.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Antimetabolite affecting RNA synthesis; might have an indirect effect on PAF1 expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interferes with the transcription process; potential effects on PAF1 expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
RNA polymerase II inhibitor; could indirectly modulate PAF1 expression. | ||||||
GSK126 | 1346574-57-9 | sc-490133 sc-490133A sc-490133B | 1 mg 5 mg 10 mg | $92.00 $243.00 $306.00 | ||
EZH2 methyltransferase inhibitor; might influence PAF1 expression through chromatin remodeling. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
DNA methyltransferase inhibitor; could modulate PAF1 expression by altering DNA methylation. | ||||||
SP2509 | 1423715-09-6 | sc-492604 | 5 mg | $284.00 | ||
LSD1 inhibitor affecting chromatin modifications; potential to influence PAF1 expression. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $37.00 $112.00 $408.00 | ||
G9a histone methyltransferase inhibitor; could affect PAF1 expression by modifying chromatin. | ||||||